Invivyd share price logo

Invivyd

NASDAQ: IVVD

$0.82

-0.01

(-1.52%)

as on

Invivyd Stock Performance

as on September 5, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.79
    $0.83
    downward going graph

    3.66%

    Downside

    1.22%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.53
    $3.07
    downward going graph

    35.65%

    Downside

    274.38%

    Upside

    downward going graph

Invivyd share price movements today

Previous Close
$0.83
Open
$0.81
Volume
2.0M
Market Cap
$246.1M
Day's Low - High
$0.79 - $0.83
52 Week Low - High
$0.53 - $3.07

Invivyd Historical Returns

1 Month Return
+ 45.67 %
3 Month Return
-24.77 %
1 Year Return
-16.29 %
3 Year Return
-54.37 %
5 Year Return
0 %

Invivyd Stock Fundamentals & Key Indicators

Check Invivyd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$246.1M

EPS (TTM)

-0.57

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-111.9M

Revenue (TTM)

58.4M

Profit Margin

-183.90%

Return On Equity TTM

-95.89%

Invivyd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Invivyd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Invivyd image
Invivyd
BUY$246.1MNANA-183.90%NA
Revolution Medicines image
Revolution Medicines
BUY$44.6B614.61%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$141.1B181.73%32.2186.04%NA
Moderna image
Moderna
BUY$60.2B-64.27%-18.66-12.57%NA
Regeneron image
Regeneron
BUY$84.8B24.12%20.1484.86%0.44%

Stock Returns calculator for Invivyd Stock including INR - Dollar returns

The Invivyd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Invivyd investment value today

Current value as on today

₹88,070

Returns

-₹11,930

(-11.93%)

Returns from Invivyd Stock

-₹17,794 (-17.79%)

Dollar Impact

₹5,865 (+5.86%)

Analyst Recommendation on Invivyd Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Invivyd. Average target price of $10

Invivyd Share Price Target

Get share price movements and forecasts by analysts on Invivyd.

What analysts predicted

91.8%UPSIDE

Target Price

$10

Current Price

$0.82

Analyzed by

3 Analysts

Target

$10.00

Invivyd target price $10, a slight upside of 91.8% compared to current price of $0.82. According to 3 analysts rating.

Indian Investors' Interest in Invivyd Stock

Search interest for Invivyd Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

Invivyd Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
2
9
13
11
11
13
17
13
14
Gross Profit
0
2
8
13
10
11
12
16
12
13
Operating Income
-46
-49
-62
-19
-16
-15
-11
-12
-43
-45
EBITDA
-42
-46
-60
-16
-15
-14
-10
-10
-40
-45
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
1
0
0
0
0
0
-
Income Before Tax
-43
-47
-60
-18
-16
-14
-10
-11
-41
-44
Income Tax Expense
0
-
-
0
-
-
-
-
-
-
Net Income
-43
-47
-60
-18
-16
-14
-10
-11
-41
-44
Net Profit Margin
0.00%
-2086.88%
-653.11%
-133.45%
-144.10%
-124.38%
-79.75%
-64.33%
-301.22%
-310.77%

Invivyd Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
25
53
Gross Profit
0
0
-2
23
49
Operating Income
-226
-248
-212
-176
-55
EBITDA
-219
-225
-205
-166
-50
Interest Expense
14
43
-
-
-
Depreciation
0
0
1
3
2
Income Before Tax
-226
-241
-198
-169
-52
Income Tax Expense
7
-6
-
-
-
Net Income
-226
-241
-198
-169
-52
Net Profit Margin
0.00%
0.00%
0.00%
-669.42%
-98.25%

Invivyd Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-47
-60
-18
-16
-14
-10
-11
-41
-44
Operating Cash Flow
-41
-41
-37
-21
-13
-8
-15
-41
-43
Investing Cash Flow
-
0
0
0
0
-
-
0
0
Financing Cash Flow
0
0
0
0
0
58
157
0
19
Change in Cash
-41
-41
-37
-21
-13
50
141
-42
-24

Invivyd Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-226
-241
-198
-169
-52
Operating Cash Flow
-184
-219
-173
-170
-58
Investing Cash Flow
-50
-230
280
0
0
Financing Cash Flow
662
0
1
39
215
Change in Cash
427
-450
108
-131
157

Mutual Funds that own Invivyd Stock

Check out the Mutual Funds with significant holdings in Invivyd.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.312479%
9763824
MUTUAL FUND SERIES TRUST
3.077769%
9071995
Fidelity Concord Street Trust
0.57459%
1693657
Driehaus Mutual Funds
0.19067%
562019
FINANCIAL INVESTORS TRUST
0.14549%
428847
See all

Global Institutional Holdings in Invivyd

Funds
Holdings
Lee Ainslie
6.44%
Joseph Edelman
6.27%
Peter Kolchinsky
5.81%
Vanguard
3.99%
iShares
3.08%
See all

Invivyd News & Key Events

  • img

    Today's Timeline - 01 September

    Tue, 04:50 PM

    -

    Invivyd appoints Marc Elia as CEO, consolidating leadership and strategic oversight amid board reshuffle.

    Tue, 04:57 PM

    -

    Invivyd updates on VYD2311 program, expects top-line data by end of Q3 2026.

    Tue, 08:15 PM

    -

    Cantor suggests Invivyd shares should trade higher after CEO appointment and study update.

Insights on Invivyd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 32.3% return, outperforming this stock by 86.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 513.1% return, outperforming this stock by 529.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IVVD stock has moved down by -13.4%

About Invivyd

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.
OrganisationInvivyd
Headquarters209 Church Street, New Haven, CT, United States, 06510
IndustryBiotechnology
CEOMr. William E. Duke Jr., M.B.A.
E-voting on sharesClick here to vote

Key Management of Invivyd

Name

Title

Ms. Julie Green M.B.A.

Chief Human Resources Officer

Ms. Rachael Gerlach Ph.D.

Senior Vice President of Regulatory Affairs

Ms. Katie Falzone CPA

Senior Vice President of Finance

Mr. William E. Duke Jr., M.B.A.

CFO, Principal Accounting Officer & Principal Executive Officer

Ms. Jill Andersen J.D.

Chief Legal Officer & Corporate Secretary

Mr. Timothy Lee

Chief Commercial Officer

Dr. Robert D. Allen Ph.D.

Chief Scientific Officer

Ms. Kristie Coneys Kuhl J.D.

Chief Communications Officer

FAQs

What is Invivyd share price today?

Invivyd share price today is $0.82 as on at the close of the market. Invivyd share today touched a day high of $0.83 and a low of $0.79.

What is the 52 week high and 52 week low for Invivyd share?

Invivyd share touched a 52 week high of $3.07 on and a 52 week low of $0.53 on . Invivyd stock price today i.e. is closed at $0.82,which is 73.29% down from its 52 week high and 55.39% up from its 52 week low.

What is Invivyd's market capitalisation today?

Invivyd market capitalisation is $0.00T as on .

How to invest in Invivyd Stock (IVVD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Invivyd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Invivyd Shares that will get you 1.8293 shares as per Invivyd share price of $0.82 per share as on September 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy Invivyd Stock (IVVD) from India?

Indian investors can start investing in Invivyd (IVVD) shares with as little as ₹94.485 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Invivyd stock (as per the Rupee-Dollar exchange rate as on ). Based on Invivyd share’s latest price of $0.82 as on September 5, 2026 at 1:29 am IST, you will get 12.1951 shares of Invivyd. Learn more about fractional shares .